M
ore people in the United States now die of prescription drug overdose than accidental vehicular trauma (1) . This startling statistic has stimulated physicians, government agencies, and various organizations to effect change through provider guidelines, patient education, and proactive legislation. Opioid analgesics, particularly oxycodone, are major contributors to this trend in preventable death.
Elected officials often erroneously point to the emergency department (ED) as a leading source of opioid prescriptions. In addition, legislative and regulatory action across the United States has called for mandatory continuing education and reclassification of hydrocodone to a schedule II drug. The mayor of New York City recently announced that public hospital emergency physicians are prohibited from prescribing more than a 3-day supply of opioids. This announcement was based on an understanding of the New York City Department of Health and Mental Hygiene's opioid prescribing guidelines (2) . The guidelines as written are largely acceptable to most physicians, although, regrettably, the mayor's office did not announce them as such and seems to have limited them to ED opioid prescribing.
As we promulgate solutions to this very old but increasingly deadly problem, it is important to properly identify the underlying causes. We must place our resources where the greatest difference can be made, without preventing timely and compassionate relief of pain. Continuing such pain relief may require a prescription for a medicine appropriate to the pain's intensity. A prescription for a 3-to 7-day supply is often sufficient for the patient who presents to an ED to obtain appropriate follow-up outpatient care.
Data from 2009 (3) show that emergency physicians write fewer than 5% of immediate-release opioid prescriptions and an even smaller proportion of extended or longacting opioid prescriptions. Yet, guidelines for emergency physicians have garnered the most attention.
Legitimate cases of pain may require opioid analgesia in excess of a 3-day supply, including for clinical entities (such as long bone fracture, recurrent pancreatitis, and vertebral compression fracture) and time considerations that prevent access to an alternate source of care (such as midweek major holidays). Emergency departments in the United States are crowded, and access to primary care is problematic, even for insured patients. If the health care reform in Massachusetts is generalizable, we will see additional increases in primary care and ED volume with the Patient Protection and Affordable Care Act. Unintended consequences of limiting emergency physicians by statute to a 3-day opioid prescription may include additional visits to the ED for pain relief while the patient seeks follow-up care, adding to crowding.
So, what should we do? First, we must educate our patients. At the pharmacy, where opioids are dispensed, there is an opportunity for "just-in-time" teaching. New technologies provide new venues, such as smart phone applications, for patient education.
Second, law enforcement is critical to preventing illicit distribution and abuse of narcotics. The U.S. Drug Enforcement Administration and some state attorneys' offices have addressed the issue with renewed vigor. For example, Florida has closed nearly 254 "pain clinics" (4). Clearly, our criminal justice system has a mandate to eliminate illicit diversion and corrupt pain clinics and to prosecute participating physicians.
To move toward these goals, many states have instituted prescription monitoring systems (5). Unfortunately, they exist largely at the state level or are impeded by inadequate funding. To be effective, pharmacies need a national system that automatically identifies opioid prescription and dispensing by pharmacy, patient, and physician. The patchwork of regulations cannot provide an effective approach to opioid misuse. Effective monitoring systems will augment clinician judgment, provide evidence of misuse, and facilitate prescription of the most appropriate analgesic for the situation.
The pharmaceutical industry has a role to play, too. It can assist the Drug Enforcement Administration in making accurate annual estimates of national opiate demand. The flow of opioids from pharmaceutical company to pharmacy to patient needs a better tracking system. The ED is regarded as the nation's safety net for many reasons, but pertinent to this discussion, it's the last bastion of around-the-clock access to care by trained medical providers. Unfortunately, some of the legislative "solutions" to opioid misuse preempt judgments from trained emergency medical providers (6) .
Emergency physicians see first-hand the devastating consequences of opioid misuse. We often pick up the pieces, from first-contact psychiatric care to acute resuscitation after overdose. Most patients receiving a prescription for an opiate legitimately need pain relief. Emergency physicians typically prescribe only a few narcotic pills at a time,
This article was published at www.annals.org on 9 April 2013. enough to last until a patient can see an outpatient medical provider. Yet, those appointments are hard to come by for many patients. Consequently, pain remains one of the top reasons people seek emergency care. There is no objective test for pain. The Joint Commission's focus on documenting pain at each clinical encounter and the desire to perform well on patient satisfaction surveys has led providers to aggressively treat pain. These forces may have led to physician discomfort when saying "no" to questionable requests for pain relief. The pendulum was pushed hard toward liberal pain relief, but it is about to move toward a safer middle ground.
Patients deserve evidence-based, individually tailored care with professional judgment. Clinical decisions regarding patients with pain should be free of incentive and prejudice.
Closing corrupt pain centers and improving access to high-quality, nonemergency care will improve the care of patients with pain. Restricting opioid prescription by emergency physicians will not solve the problem of opioid misuse. These physicians are on the front lines, treating more than 130 million patients each year who come to them with various ailments (7) . Clinical policies for opioid prescription must not inhibit their ability to compassionately treat patients who legitimately seek pain relief in the ED (8, 9) . Author contributions are available at www.annals.org.
